The IL6/STAT3 activation enhances myeloma cell survival through the activation of anti-apoptotic genes, Mcl-1, Bcl-XL and c-Myc oncogene (Manier et al. 2012). The gene discussed is MYC; the disease is plasma cell myeloma.